Ditchcarbon
  • Contact
  1. Organizations
  2. Acino
Public Profile
Pharmaceutical Preparation Manufacturing
CH
updated 20 days ago

Acino

Company website

Acino, officially known as Acino Pharma AG, is a prominent player in the pharmaceutical industry, headquartered in Switzerland (CH). Founded in 2007, the company has rapidly expanded its operations across Europe, the Middle East, and Africa, establishing a strong presence in these key regions. Acino focuses on developing and manufacturing high-quality generic and specialty pharmaceuticals, with a particular emphasis on innovative drug delivery systems. Their unique approach to formulation and packaging sets them apart in a competitive market. With a commitment to improving patient outcomes, Acino has achieved significant milestones, including numerous product launches and strategic partnerships. The company is recognised for its robust portfolio and dedication to quality, positioning it as a trusted name in the pharmaceutical landscape.

DitchCarbon Score

How does Acino's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

29

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Acino's score of 29 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.

53%

Let us know if this data was useful to you

Acino's reported carbon emissions

In 2023, Acino reported significant carbon emissions, with total Scope 1 emissions amounting to approximately 2,787,000 kg CO2e and Scope 2 emissions at zero kg CO2e in Switzerland (CH). Globally, the company recorded total emissions of about 5,047,200 kg CO2e for Scope 1 and approximately 3,209,000 kg CO2e for Scope 2, resulting in a combined total of around 8,256,500 kg CO2e. Acino is committed to achieving carbon neutrality by 2050, focusing on both Scope 1 and Scope 2 emissions. In 2023, the company initiated efforts to better understand its emissions profile and implement activities aimed at reaching this long-term goal. While specific reduction targets have not been detailed, the commitment to carbon neutrality reflects a proactive approach to climate action. The emissions data reported by Acino is cascaded from its parent company, Acino International AG, indicating a structured approach to sustainability within the corporate family. As the company progresses towards its climate commitments, it aims to enhance its operational efficiency and reduce its carbon footprint in alignment with industry standards.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2023
Scope 1
5,047,200
Scope 2
3,209,000
Scope 3
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Acino's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Acino is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Acino is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Jamjoom Pharmaceuticals Factory Company

SA
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Sanofi SA

CH
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy